29 September 2020 : Case report
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy
Unusual clinical course, Diagnostic / therapeutic accidents, Unusual setting of medical care, Unexpected drug reaction , Educational Purpose (only if useful for a systematic review or synthesis)Anna Moniuszko-Malinowska1ABDEFG*, Piotr Czupryna1ABDEF, Barbara Boczkowska-Radziwon2BDEF, Tomasz Wasiluk2BDEF, Karol Borawski1BDE, Justyna Dunaj1BD, Magdalena Bujno2BD, Piotr Radziwon23BDE, Krzysztof Rutkowski4D, Sławomir Pancewicz1ABDE
Am J Case Rep 2020; 21:e927662
BACKGROUND: There is no evidence-based treatment for coronavirus disease 2019 (COVID-19). We report the case of a 63-year-old woman with SARS-CoV-2 infection who developed severe COVID-19 pneumonia and was treated with convalescent plasma.
CASE REPORT: A 63-year-old woman who presented with severe and prolonged course of COVID-19 disease (fever up to 39.4°C, persistent cough, and dyspnea) received a convalescent plasma transfusion, which led to complete recovery. The diagnosis was confirmed by RT-PCR testing using the CFX96 Real-Time System (Bio-Rad, USA) from nasopharyngeal swabs. In laboratory tests, an increase in acute-phase parameters was observed. Chest computed tomography (CT) showed abnormalities typical for COVID-19. On days 9 and 11 of the disease, she received the convalescent plasma prepared from a single plasmapheresis donation from a male donor. This male donor was qualified as a convalescent plasma donor according to Polish guidelines, which are compliant with European guidelines. He donated plasma at the Regional Centre for Transfusion Medicine in Białystok, Poland. The therapy with convalescent plasma led to clinical improvement and normalization of inflammatory parameters.
CONCLUSIONS: This report presents a case of severe COVID-19 pneumonia in a 63-year-old woman who was given supportive treatment with convalescent plasma. Ongoing clinical trials will determine whether convalescent plasma therapy is an effective treatment for SARS-CoV-2 infection.
Keywords: Antibodies, Complementary Therapies, COVID-19
26 November 2021 : EditorialEditorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
Med Sci Monit In Press; DOI: 10.12659/MSM.935624
26 November 2021 : Case reportArteritic Anterior Ischemic Optic Neuropathy in the Course of Giant Cell Arteritis After COVID-19
Am J Case Rep In Press; DOI: 10.12659/AJCR.933471
26 October 2021 : Case reportProgressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report
Am J Case Rep In Press; DOI: 10.12659/AJCR.933458
29 Nov 2021 : Case reportA 58-Year-Old Woman with Gallstones, Chronic Pancreatitis, and Pancreatic Pseudocyst Presenting with Pleura...
Am J Case Rep In Press; DOI: 10.12659/AJCR.934247
29 Nov 2021 : Case reportAcute Perforated Appendicitis Associated with Appendiceal Diverticulitis in a Young Man: A Case Report with...
Am J Case Rep In Press; DOI: 10.12659/AJCR.934838
26 Nov 2021 : Case reportA Case of Metaplastic Squamous Cell Carcinoma of the Breast that Showed a Pathological Complete Response Af...
Am J Case Rep In Press; DOI: 10.12659/AJCR.935035
Most Viewed Current Articles
15 Aug 2020 : Case reportA 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodul...
Am J Case Rep 2020; 21:e926779
09 May 2019 : Case reportA Rare Case of Stage IV Basaloid Squamous Cell Cancer with Intrapulmonary and Brain Metastases
Am J Case Rep 2019; 20:664-667
13 Mar 2019 : Case reportDry Beriberi Due to Thiamine Deficiency Associated with Peripheral Neuropathy and Wernicke’s Encephalopathy...
Am J Case Rep 2019; 20:330-334